Ovarian reserve screening with anti- Müllerian hormone

Authors

  • Iván Reyes-Armas Médico Gineco-obstetra, Especialista en Infertilidad; Máster en Reproducción Humana; Servicio de Reproducción Humana, Hospital Nacional Docente San Bartolomé, Lima, Perú; Universidad Científica del Sur, Lima, Perú
  • Flor Carvallo Ñiquen Médico Gineco-obstetra, Especialista en Infertilidad

DOI:

https://doi.org/10.31403/rpgo.v64i2094

Abstract

Currently, ovarian reserve (OR) tests are mainly used in the evaluation of subfertile patients. In this paper, we discuss the use of anti-Müllerian hormone (AMH) levels, which have been associated in some cases with antral follicle count (AFC) and FSH levels in young women, and we propose an algorithm to identify the risk of reduced ovarian reserve. Using her full autonomy and after counseling, the woman would decide whether or not to do the tests, according to her priorities in life. If these tests were altered, the woman could modify her plans in regard to motherhood.

Downloads

Download data is not yet available.

Downloads

Published

2018-09-28

Issue

Section

Artículos de Opinión